Skip to content

EOI Block for Laparoscopic Gastrostomy

Effect of Ultrasound-guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Laparoscopic Gastrostomy: A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07119346
Enrollment
40
Registered
2025-08-13
Start date
2025-08-31
Completion date
2028-05-31
Last updated
2025-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrostomy

Brief summary

This randomized controlled trial will evaluate the efficacy of ultrasound-guided external oblique intercostal fascial plane (EOI) block in reducing intraoperative and postoperative pain in pediatric patients undergoing laparoscopic gastrostomy under general anesthesia. Forty patients aged 3-18 years will be randomly allocated to receive either bilateral EOI block with 0.25% ropivacaine or sham block with normal saline. Primary outcome is percent change in heart rate at surgical incision. Secondary outcomes include intraoperative fentanyl use, perioperative analgesic requirements, postoperative pain scores (r-Face, Legs, Activity, Cry, Consolability(r-FLACC) and Pediatric Pain Profile), Analgesia Nociception Index values, and analgesia-related adverse events.

Interventions

PROCEDUREEOI block

EOI block with 0.25% ropivacaine 1 mL/kg (max 40 mL) bilaterally under ultrasound guidance

PROCEDUREsham block

Sham block with equal volume of normal saline bilaterally under ultrasound guidance

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for laparoscopic gastrostomy at Seoul National University Children's Hospital Age ≥3 and \<18 years

Exclusion criteria

* Unstable vital signs Contraindications to ropivacaine or opioids Severe hepatic or renal dysfunction Other investigator-determined ineligibility

Design outcomes

Primary

MeasureTime frameDescription
Percent change in heart rate at surgical incisionAt surgical incision (baseline immediately before incision and within 10 minutes after incision).Post-incision HR - Pre-incision HR) / Pre-incision HR × 100

Secondary

MeasureTime frameDescription
Percent change in mean arterial pressure at incisionAt surgical incision (baseline immediately before incision and within 10 minutes after incision).
Intraoperative max-min heart rateIntraoperative period (skin incision to end of surgery).
Intraoperative max-min mean arterial pressureIntraoperative period (skin incision to end of surgery).
ANI time-weighted average outside target (50-80)From induction of anesthesia to end of anesthesia (arrival to PACU).
r-Face, Legs, Activity, Cry, Consolability pain scoresAt PACU 15 minutes and 30 minutes; and at 1, 3, 6, and 24 hours after surgery.
Intraoperative fentanyl useFrom induction of anesthesia to end of surgery.
analgesia nociception index (ANIm) values in PACUAt 15 and 30 minutes after PACU arrival.
Non-opioid analgesic consumption (mg/kg)From end of surgery to 24 hours postoperatively.
Opioid analgesic consumption (mcg/kg)From end of surgery to 24 hours postoperatively.
Analgesic-related adverse effectsUp to 24 hours after surgery.nausea, vomiting, pruritus
Pediatric Pain Profile score24 hours after surgery.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026